Professor of Medicine Mayo Clinic, MN, United States
Disclosure(s):
Maricar F. Malinis, MD: Moderna ( concluded): Advisor/Consultant; Paratek Pharmaceuticals, Inc.: Honoraria
Raymund Razonable, MD: Allovir, Inc: Advisor/Consultant (Terminated, April 17, 2024); American Society of Transplantation: Board Member (Ongoing); Gilead Biosciences: Grant/Research Support (Terminated, April 17, 2024); Glaxo Smith Kline: Advisor/Consultant (Terminated, April 17, 2024); Regeneron, Inc: Grant/Research Support (Terminated, April 17, 2024); Roche Pharmaceuticals: Grant/Research Support (Terminated, April 17, 2024)